Facebook Twitter Instagram
    Facebook Twitter YouTube Instagram
    Latest Articles
    • Submissions open for the Kerry Group Irish Novel of the Year Award 2027
    • Trinity research shows no link between water fluoridation and cognitive decline in older Irish adults
    • An Introduction to Irish Family History at EPIC
    • Thinking of Fostering?
    • Galway 50 Plus Show Presentation Schedule Announced
    • Galway wins Bus Éireann GEMs West Depot of the Year
    • Lets Talk Books – Mairead Robinson meets health food advocate Sophie Morris
    • Michael Jackson treasures opens at the Museum of Style Icons, Newbridge
    Senior Times
    Podcasts
    • Home
    • News
    • Features
      • Fashion & Beauty
      • Finance
      • Food & Wine
      • Further Education
      • Gardening
      • Health
      • Hobbies & Pastimes
      • Legal
      • Literature
      • Nostalgia
      • Profiles
      • 50 Plus Show
      • Sport
      • Travel
      • What’s On
    • Podcasts
      • All Podcasts
      • Driving Life
      • Irish Gen Pod Series
      • Your Money Your Choice
      • Mind It! with Sinead Ryan
      • Garry Cooke’s Lions Legends
    • Competitions
    • 50 Plus Show
      • Whats On
      • Register To Attend
      • Exhibitors
    • Magazine
      • SeniorTimes Digital Issues
      • Subscribe
      • Advertise
    • Meeting Place
    • Contact
    Senior Times
    You are at:Home»Features»Health»Brain’s immune cells put the brakes on out-of-control circuits in mouse model of Alzheimer’s disease

    Brain’s immune cells put the brakes on out-of-control circuits in mouse model of Alzheimer’s disease

    0
    By Senior Times on July 20, 2026 Health

    Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain play a critical role in maintaining the stability of neuronal networks in Alzheimer’s disease

    Crucially, this suggests treatments that indiscriminately suppress these cells could be counterproductive

    Microglia, by driving brain inflammation, are generally considered to accelerate Alzheimer’s disease. But the study, published in leading neurology journal Brain, found that reducing the number and activity of these cells unexpectedly worsened abnormal electrical activity in the brain and increased seizure-like events. 

    Alzheimer’s disease affects more than 55 million people worldwide and is the leading cause of dementia. While memory loss is its best-known symptom, scientists increasingly recognise that the disease also disrupts the brain’s electrical activity, affecting how networks of neurons communicate with one another.

    In the new study, researchers from Trinity’s School of Biochemistry and Immunology, and School of Medicine, examined these changes in a widely used mouse model of Alzheimer’s disease.

    The research, driven by PhD student Dr Hugh Delaney, revealed that normal patterns of brain activity associated with learning and memory became weaker, while abnormal electrical activity became more common. Some of these changes resembled the excessive activity seen in epilepsy, which is increasingly recognised as an underappreciated feature of Alzheimer’s disease and may contribute to cognitive decline.

    To test whether reducing microglial activity might improve brain function, the team treated mice with a drug that blocks “Colony Stimulating Factor 1 Receptor (CSF1R)”, a target currently being explored in experimental treatments for neurodegenerative disease. The results were unexpected. Although the treatment reduced the number of microglial cells and partially protected connections between neurons, it did not improve memory performance. Instead, it led to a marked increase in abnormal electrical activity within brain networks, including more severe seizure-like events.

    The researchers also found evidence that the treatment reduced the ability of microglia to remove potentially problematic synaptic connections between neurons, suggesting that these immune cells may be working to keep brain circuits stable and to limit excessive neuronal activity during disease progression.

    Professor Mark Cunningham, Professor of Physiology in Trinity’s School of Medicine and senior author of the study, said: “We expected that reducing microglial activation might improve the function of brain networks affected by Alzheimer’s disease. Instead, we found the opposite. When microglia were suppressed, the brain became more electrically unstable and more prone to abnormal activity.”

    Professor Colm Cunningham, Professor of Neuroscience in Trinity’s School of Biochemistry and Immunology and co-senior author, added: “Microglia have often been viewed as drivers of harmful inflammation in Alzheimer’s disease. Our findings indicate that the story is more complex. These cells are also performing important housekeeping functions that help maintain healthy brain activity. If we interfere with those functions, there may be unintended consequences.”

    What is the potential impact of this research?

    The study is particularly significant because therapies designed to alter microglial activity are currently being investigated as potential treatments for Alzheimer’s disease.

    The researchers say their findings do not rule out microglia as a therapeutic target, however. Instead, they suggest that future treatments will need to distinguish between harmful inflammatory processes and the beneficial roles microglia play in maintaining healthy brain function.

    The work also strengthens growing evidence that abnormal electrical activity in the brain is an important feature of Alzheimer’s disease and may represent an important target for future therapies.

    The published journal article is at: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awag147/8733843?searchresult=1&login=true. A PDF is available on request. It was supported by funding from Research Ireland, a John Scott Studentship, a Government of Ireland Postgraduate Scholarship, and the National Institutes of Health. 

    Spread the love
    Senior Times
    • Website
    • Facebook
    • Instagram
    • LinkedIn

    Senior Times publishes Senior Times magazine and are producers of the SeniorTimes Podcasts. They are also organisers of The 50 Plus Show run throughout the country

    Related Posts

    Trinity research shows no link between water fluoridation and cognitive decline in older Irish adults

    The essential role of rehabilitation….

    5 Winners Selected for a 3 month supply of Procydin

    Comments are closed.



    REGISTER TO ATTEND THE 50 PLUS SHOW

    Mind It! with Sinead Ryan

    Search the Site
    Spotify

    Subscribe

    Subscribe to Our Newlsetter
    * indicates required

    Follow Us On Facebook
    Follow us on YouTube

    Next up on the 50 Plus Show Calendar is our Sligo event on the 3rd of July. And as always we have a full line up of displays, demonstrations and workshops designed to inform and entertain. Admission is free by going to https://t.co/OnB9lXrHYB@radissonsligo @sligococo @sligo pic.twitter.com/FIxFchlGVl

    — Senior Times (@SeniorTimesMag) May 19, 2025
    Copyright © 2026 Sports & Leisure. Designed by clikcreative.com.

    Type above and press Enter to search. Press Esc to cancel.